env Gene Products, Human Immunodeficiency Virus
"env Gene Products, Human Immunodeficiency Virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins encoded by the ENV GENE of the HUMAN IMMUNODEFICIENCY VIRUS.
MeSH Number(s)
D12.776.964.775.325.164
D12.776.964.775.562.500
D12.776.964.970.880.325.164
Below are MeSH descriptors whose meaning is more general than "env Gene Products, Human Immunodeficiency Virus".
Below are MeSH descriptors whose meaning is more specific than "env Gene Products, Human Immunodeficiency Virus".
This graph shows the total number of publications written about "env Gene Products, Human Immunodeficiency Virus" by people in Harvard Catalyst Profiles by year, and whether "env Gene Products, Human Immunodeficiency Virus" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 6 | 7 |
| 2009 | 6 | 4 | 10 |
| 2010 | 4 | 3 | 7 |
| 2011 | 9 | 5 | 14 |
| 2012 | 5 | 7 | 12 |
| 2013 | 9 | 7 | 16 |
| 2014 | 13 | 8 | 21 |
| 2015 | 7 | 6 | 13 |
| 2016 | 10 | 2 | 12 |
| 2017 | 8 | 10 | 18 |
| 2018 | 11 | 6 | 17 |
| 2019 | 16 | 9 | 25 |
| 2020 | 10 | 5 | 15 |
| 2021 | 2 | 0 | 2 |
Below are the most recent publications written about "env Gene Products, Human Immunodeficiency Virus" by people in Profiles.
-
Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions. J Virol. 2021 01 13; 95(3).
-
Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses. J Virol. 2021 01 13; 95(3).
-
RV144 HIV-1 vaccination impacts post-infection antibody responses. PLoS Pathog. 2020 12; 16(12):e1009101.
-
HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana. Viruses. 2020 12 07; 12(12).
-
Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor. J Virol. 2020 10 14; 94(21).
-
Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands. J Virol. 2020 08 17; 94(17).
-
Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein. Nat Commun. 2020 05 08; 11(1):2317.
-
VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA. Cell Host Microbe. 2020 06 10; 27(6):963-975.e5.
-
Envelope characteristics in individuals who developed neutralizing antibodies targeting different epitopes in HIV-1 subtype C infection. Virology. 2020 07; 546:1-12.
-
Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models. Proc Natl Acad Sci U S A. 2020 04 07; 117(14):7929-7940.